Thank you, Madam Chair. I would like to thank the witnesses for being here to discuss such an important subject.
My two questions will be mostly financial in nature. Dr. Engelhardt told us at the beginning that the $88 million set aside for this project would be invested, at least for the most part, in the fight against HIV. He also told us that an evaluation process was underway in order to determine where that money would go and how it could be invested.
I wonder as well—this is the first question I would like to ask the witnesses—where should the money go? The second question is: is putting $88 million into the research facility the best use of the money? Could something else be done? The witnesses are in a position to answer that question, I feel.